Sec Form 13G Filing - SUVRETTA CAPITAL MANAGEMENT LLC filing for PALVELLA THERAPEUTICS INC. (PVLA) - 2024-12-20

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
SCHEDULE 13G 0001569064 XXXXXXXX LIVE Common stock, $0.001 par value per share 12/13/2024 0001583648 Palvella Therapeutics, Inc. 697947109 540 Madison Avenue 7th Floor New York NY 10022 Rule 13d-1(c) SUVRETTA CAPITAL MANAGEMENT, LLC b DE 0.00 714463.00 0.00 714463.00 714463.00 N 8.6 IA OO Averill Master Fund, Ltd. b E9 0.00 714463.00 0.00 714463.00 714463.00 N 8.6 CO Aaron Cowen b X1 0.00 714463.00 0.00 714463.00 714463.00 N 8.6 HC IN Palvella Therapeutics, Inc. 125 Strafford Avenue, Suite 360, Wayne, Pennsylvania 19087 Suvretta Capital Management, LLC Averill Master Fund, Ltd. Aaron Cowen Suvretta Capital Management, LLC 540 Madison Avenue, 7th Floor New York, New York 10022 United States of America Averill Master Fund, Ltd. c/o Maples Corporate Services Limited P.O. Box 309 Ugland House Grand Cayman KY1-1104 Cayman Islands Aaron Cowen c/o Suvretta Capital Management, LLC 540 Madison Avenue, 7th Floor New York, New York 10022 Suvretta Capital Management, LLC - Delaware Averill Master Fund, Ltd. - Cayman Islands Aaron Cowen - United States Y Suvretta Capital Management, LLC - 714,463 Averill Master Fund, Ltd. - 714,463 Aaron Cowen - 714,463 Suvretta Capital Management, LLC - 8.6% Averill Master Fund, Ltd. - 8.6% Aaron Cowen - 8.6% Suvretta Capital Management, LLC - 0 Averill Master Fund, Ltd. - 0 Aaron Cowen - 0 Suvretta Capital Management, LLC - 714,463 Averill Master Fund, Ltd. - 714,463 Aaron Cowen - 714,463 Suvretta Capital Management, LLC - 0 Averill Master Fund, Ltd. - 0 Aaron Cowen - 0 Suvretta Capital Management, LLC - 714,463 Averill Master Fund, Ltd. - 714,463 Aaron Cowen - 714,463 Y N All of the securities reported in this Schedule 13G are directly owned by advisory clients of Suvretta Capital Management, LLC. None of those advisory clients, other than Averill Master Fund, Ltd., may be deemed to beneficially own more than 5% of the Common Stock, $0.001 par value per share. N Please see Exhibit B attached hereto. Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. [Exhibit A - Joint Filing Agreement] [Exhibit B - Control Person Identification] SUVRETTA CAPITAL MANAGEMENT, LLC /s/ Aaron Cowen 12/20/2024 Averill Master Fund, Ltd. /s/ Aaron Cowen 12/20/2024 Aaron Cowen /s/ Aaron Cowen 12/20/2024 * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.